• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米技术在癌症治疗、诊断及管理中的应用。

Nanotechnology in cancer therapeutics, diagnosis, and management.

作者信息

Hazarika Disha, Sarma Sumit, Shankarishan Priyanka

机构信息

University of Science and Technology Meghalaya (USTM), Meghalaya, India.

出版信息

BioTechnologia (Pozn). 2024 Sep 30;105(3):287-303. doi: 10.5114/bta.2024.141807. eCollection 2024.

DOI:10.5114/bta.2024.141807
PMID:39439717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11492894/
Abstract

Nanotechnology presents an exciting opportunity in cancer research by offering significant advancements in therapies, diagnosis, and management. It possesses unparalleled potential to enhance the accuracy and effectiveness of cancer therapy while simultaneously reducing adverse effects, owing to its distinctive capability to manipulate matter at a molecular level. Using nanoparticle carriers has facilitated the precise administration of therapeutic agents to afflicted areas within the human body through customized drug delivery systems, resulting in improved treatment accuracy and efficacy while reducing adverse effects. These techniques improve drug solubility and stability, leading to elevated levels of biochemical availability and improved efficacy outcomes for patients with minimal negative effects during treatment cycles. Another use case for nanoparticles includes tumor imaging; functionalized with targeting ligands containing diagnostic agents, they foster early detection, making quicker remedial action plans possible. Overall, the incorporation of nanotechnology ensures a promising future, although it stresses the need to address regulatory hurdles and safety concerns before widespread clinical implementation. Despite the complexity of cancer research and patient care, nanotechnology shows promise in transforming both fields.

摘要

纳米技术在癌症研究中提供了一个令人兴奋的机会,在治疗、诊断和管理方面取得了重大进展。由于其在分子水平上操纵物质的独特能力,它具有无与伦比的潜力来提高癌症治疗的准确性和有效性,同时减少不良反应。使用纳米颗粒载体通过定制的药物递送系统促进了治疗剂在人体内患病区域的精确给药,从而提高了治疗的准确性和疗效,同时减少了不良反应。这些技术提高了药物的溶解度和稳定性,从而提高了生化利用度,改善了治疗效果,且在治疗周期中对患者的负面影响最小。纳米颗粒的另一个应用案例是肿瘤成像;用含有诊断剂的靶向配体进行功能化后,它们有助于早期检测,从而制定更快的补救行动计划。总体而言,尽管纳米技术强调在广泛临床应用之前需要解决监管障碍和安全问题,但它的应用确保了一个充满希望的未来。尽管癌症研究和患者护理很复杂,但纳米技术在改变这两个领域方面显示出了前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/0ee31c00d20d/BTA-105-3-54528-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/013b0b7d6ec6/BTA-105-3-54528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/d0782962d63f/BTA-105-3-54528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/04e0ecfe1ead/BTA-105-3-54528-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/ee3744f8094b/BTA-105-3-54528-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/0ee31c00d20d/BTA-105-3-54528-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/013b0b7d6ec6/BTA-105-3-54528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/d0782962d63f/BTA-105-3-54528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/04e0ecfe1ead/BTA-105-3-54528-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/ee3744f8094b/BTA-105-3-54528-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0b/11492894/0ee31c00d20d/BTA-105-3-54528-g005.jpg

相似文献

1
Nanotechnology in cancer therapeutics, diagnosis, and management.纳米技术在癌症治疗、诊断及管理中的应用。
BioTechnologia (Pozn). 2024 Sep 30;105(3):287-303. doi: 10.5114/bta.2024.141807. eCollection 2024.
2
Diabetology and Nanotechnology: A Compelling Combination.糖尿病学与纳米技术:引人注目的结合。
Recent Pat Nanotechnol. 2025;19(1):4-16. doi: 10.2174/0118722105253055231016155618.
3
Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma.纳米技术在肝细胞癌诊断与治疗中的进展
J Clin Med. 2023 Oct 31;12(21):6867. doi: 10.3390/jcm12216867.
4
Nanotechnology for Cancer Imaging: Advances, Challenges, and Clinical Opportunities.癌症成像的纳米技术:进展、挑战与临床机遇。
Radiol Imaging Cancer. 2021 May;3(3):e200052. doi: 10.1148/rycan.2021200052.
5
Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.近期药物设计领域的进展:挖掘新型疗法的潜力。
Curr Pharm Biotechnol. 2024;25(16):2060-2077. doi: 10.2174/0113892010275850240102105033.
6
Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.纳米技术和姜黄素:消化道癌症治疗的新方法和新希望。
Nanomedicine (Lond). 2023 Nov;18(27):2081-2099. doi: 10.2217/nnm-2023-0213. Epub 2023 Dec 11.
7
Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.用于视网膜母细胞瘤诊断与治疗的多功能纳米材料和纳米颗粒
Biosensors (Basel). 2021 Mar 26;11(4):97. doi: 10.3390/bios11040097.
8
Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.基于纳米颗粒的小分子抗糖尿病药物给药系统:一种有效的治疗新范例。
Acta Biomater. 2018 Nov;81:20-42. doi: 10.1016/j.actbio.2018.09.049. Epub 2018 Sep 28.
9
Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.用纳米治疗和纳米诊断靶向癌细胞:现状和未来展望。
Semin Cancer Biol. 2021 Feb;69:52-68. doi: 10.1016/j.semcancer.2020.01.011. Epub 2020 Jan 31.
10
Advancements of metallic nanoparticles: A promising frontier in cancer treatment.金属纳米粒子的进展:癌症治疗的一个有前途的前沿领域。
Sci Prog. 2024 Oct-Dec;107(4):368504241274967. doi: 10.1177/00368504241274967.

引用本文的文献

1
Synthesis, Characterization, and In Vitro Cytotoxic Evaluation of Neodymium-Doped Cobalt Ferrite Nanoparticles on Human Cancer Cell Lines.掺钕钴铁氧体纳米颗粒对人癌细胞系的合成、表征及体外细胞毒性评价
Materials (Basel). 2025 Aug 21;18(16):3911. doi: 10.3390/ma18163911.
2
Capture and detection of extracellular vesicles derived from human breast cancer cells using a 3D self-assembled nanostructured SiO microfluidic chip.使用3D自组装纳米结构SiO微流控芯片捕获和检测源自人乳腺癌细胞的细胞外囊泡。
J Biol Eng. 2025 Jul 29;19(1):71. doi: 10.1186/s13036-025-00512-0.
3
Smart nanomedicines powered by artificial intelligence: a breakthrough in lung cancer diagnosis and treatment.

本文引用的文献

1
Liposomal drug formulations for treatment of hematological malignancies.用于治疗血液系统恶性肿瘤的脂质体药物制剂。
Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1911-1914. doi: 10.1080/14656566.2023.2269086. Epub 2024 Jan 5.
2
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.推进纳米技术以改善癌症靶向治疗:克服其临床实施中的障碍。
Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0.
3
Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols.
由人工智能驱动的智能纳米药物:肺癌诊断与治疗的一项突破。
Med Oncol. 2025 Mar 25;42(5):134. doi: 10.1007/s12032-025-02680-x.
4
Nanostructured Formulations for a Local Treatment of Cancer: A Mini Review About Challenges and Possibilities.用于癌症局部治疗的纳米结构制剂:关于挑战与可能性的综述
Pharmaceutics. 2025 Feb 6;17(2):205. doi: 10.3390/pharmaceutics17020205.
5
Maytansinoids in cancer therapy: advancements in antibody-drug conjugates and nanotechnology-enhanced drug delivery systems.美登素类药物在癌症治疗中的应用:抗体-药物偶联物及纳米技术增强药物递送系统的进展
Discov Oncol. 2025 Jan 21;16(1):73. doi: 10.1007/s12672-025-01820-z.
脂质体作为药品上市批准的特征分析:分析方法、指导原则和标准化方案。
J Pharm Biomed Anal. 2023 Nov 30;236:115751. doi: 10.1016/j.jpba.2023.115751. Epub 2023 Sep 27.
4
Current Advances in the Biomedical Applications of Quantum Dots: Promises and Challenges.当前量子点在生物医学应用中的进展:前景与挑战。
Int J Mol Sci. 2023 Aug 11;24(16):12682. doi: 10.3390/ijms241612682.
5
Nanotechnology boosts the efficiency of tumor diagnosis and therapy.纳米技术提高了肿瘤诊断和治疗的效率。
Front Bioeng Biotechnol. 2023 Jul 28;11:1249875. doi: 10.3389/fbioe.2023.1249875. eCollection 2023.
6
Circulating tumour cells for early detection of clinically relevant cancer.循环肿瘤细胞用于早期检测临床相关癌症。
Nat Rev Clin Oncol. 2023 Jul;20(7):487-500. doi: 10.1038/s41571-023-00781-y. Epub 2023 Jun 2.
7
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.脂质体在癌症治疗中的应用:我们从何出发,又身在何处。
Int J Mol Sci. 2023 Apr 1;24(7):6615. doi: 10.3390/ijms24076615.
8
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.CPX-351 与欧洲白血病网络 2017 年高危/继发性 AML 老年患者 7+3 化疗的疗效和安全性:一项随机、3 期试验的事后分析,按欧洲白血病网络 2017 年风险亚组划分。
J Hematol Oncol. 2022 Oct 26;15(1):155. doi: 10.1186/s13045-022-01361-w.
9
Biosensor-Integrated Drug Delivery Systems as New Materials for Biomedical Applications.生物传感器集成药物输送系统作为生物医学应用的新材料。
Biomolecules. 2022 Aug 29;12(9):1198. doi: 10.3390/biom12091198.
10
Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis.纳米技术:癌症诊断、治疗和治疗学的有前途的方法。
Int J Nanomedicine. 2022 Aug 26;17:3735-3749. doi: 10.2147/IJN.S378074. eCollection 2022.